ANALYSIS OF TICAGRELOR AND PRASUGREL CORRELATION WITH CYP2C19 GENETIC VARIANTS AS ALTERNATIVE DRUGS FOR CLOPIDOGREL

被引：0
|
作者：
Seo, B. [1 ]
Lee, S. [1 ]
Lee, I. [1 ]
Kim, S. [1 ]
Chiang, J. [1 ]
机构：
[1] Cipherome, San Jose, CA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2023年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-022
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [21] Association of genetic variants in CYP2C19 and adverse clinical outcomes after treatment with clopidogrel: An updated meta-analysis
    Liu, Yan Ping
    Hao, Pan Pan
    Zhang, Ming Xiang
    Zhang, Cheng
    Gao, Fei
    Zhang, Yun
    Chen, Yu Guo
    THROMBOSIS RESEARCH, 2011, 128 (06) : 593 - 594
  • [22] CYP2C19*2 polymorphism and clopidogrel resistance
    Joob, Beuy
    Wiwanitkit, Viroj
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2020, 90 (04): : 505 - 505
  • [23] Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy
    Sibbing, D.
    Gebhard, D.
    Koch, W.
    Braun, S.
    Stegherr, J.
    Morath, T.
    Von Beckerath, N.
    Mehilli, J.
    Schoemig, A.
    Schuster, T.
    Kastrati, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (08) : 1685 - 1693
  • [24] MECHANISM-BASED INHIBITION OF HUMAN CYP2C19 BY ANTIPLATELET AGENTS TICLOPIDINE, CLOPIDOGREL AND PRASUGREL
    Nishiya, Yumi
    Hagihara, Katsunobu
    Tajima, Masami
    Miura, Shin-ichi
    Kurihara, Atsushi
    Farid, Nagy A.
    Ikeda, Toshihiko
    DRUG METABOLISM REVIEWS, 2007, 39 : 135 - 135
  • [25] Influence of Smoking on CYP2C19 Genetic Variants and Clopidogrel Efficacy in Patients with Minor Stroke or TIA.
    Wang, Tingting
    Pan, Yuesong
    Lin, Jinxi
    Anand, Raja
    Johnston, S. Claiborne
    Wang, Yongjun
    Wang, Yilong
    STROKE, 2019, 50
  • [26] EFFECT OF VONOPRAZAN ON THE ANTI-PLATELET FUNCTION OF CLOPIDOGREL OR PRASUGREL IN RELATION TO CYP2C19 GENOTYPE
    Kagami, Takuma
    Yamade, Mihoko
    Ichikawa, Hitomi
    Uotani, Takahiro
    Sahara, Shu
    Hamaya, Yasushi
    Iwaizumi, Moriya
    Osawa, Satoshi
    Sugimoto, Ken
    Miyajima, Hiroaki
    Furuta, Takahisa
    GASTROENTEROLOGY, 2017, 152 (05) : S150 - S151
  • [27] Clopidogrel Inhibits CYP2C19-Dependent Hydroxylation of Omeprazole Related to CYP2C19 Genetic Polymorphisms
    Chen, B. L.
    Chen, Y.
    Tu, J. H.
    Li, Y. L.
    Zhang, W.
    Li, Q.
    Fan, L.
    Tan, Z. R.
    Hu, D. L.
    Wang, D.
    Wang, L. S.
    OuYang, D. S.
    Zhou, H. H.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (05): : 574 - 581
  • [28] CYP2C19 GENETIC VARIATION AND INDIVIDUALIZED CLOPIDOGREL PRESCRIPTION IN A CARDIOLOGY CLINIC
    Mirabbasi, S. A.
    Khalighi, K.
    Khalighi, B.
    Kodali, A.
    Wu, Y.
    Fan, W.
    CARDIOLOGY, 2016, 134 : 242 - 242
  • [29] Effects of Omeprazole and Genetic Polymorphism of CYP2C19 on the Clopidogrel Active Metabolite
    Boulenc, Xavier
    Djebli, Nassim
    Shi, Juan
    Perrin, Laurent
    Brian, William
    Van Horn, Robert
    Hurbin, Fabrice
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (01) : 187 - 197
  • [30] EFFECT OF CLOPIDOGREL OR TICAGRELOR ON PCI PLATELET INHIBITION RATE IN PATIENTS WITH DIFFERENT CYP2C19 ALLELES
    Jiang, Zhen
    Li, Sai
    Li, Yinjun
    Jin, Xiaoyu
    Bao, Bo
    Wang, Yang
    ACTA MEDICA MEDITERRANEA, 2020, 36 (01): : 299 - 303
12345